Earlier testing for HIV--how do we prevent late presentation?

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Earlier testing for HIV--how do we prevent late presentation? / Yazdanpanah, Yazdan; Lange, Joep; Gerstoft, Jan; Cairns, Gus.

In: Antiviral Therapy, Vol. 15 Suppl 1, 01.01.2010, p. 17-24.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Yazdanpanah, Y, Lange, J, Gerstoft, J & Cairns, G 2010, 'Earlier testing for HIV--how do we prevent late presentation?', Antiviral Therapy, vol. 15 Suppl 1, pp. 17-24. https://doi.org/10.3851/IMP1526

APA

Yazdanpanah, Y., Lange, J., Gerstoft, J., & Cairns, G. (2010). Earlier testing for HIV--how do we prevent late presentation? Antiviral Therapy, 15 Suppl 1, 17-24. https://doi.org/10.3851/IMP1526

Vancouver

Yazdanpanah Y, Lange J, Gerstoft J, Cairns G. Earlier testing for HIV--how do we prevent late presentation? Antiviral Therapy. 2010 Jan 1;15 Suppl 1:17-24. https://doi.org/10.3851/IMP1526

Author

Yazdanpanah, Yazdan ; Lange, Joep ; Gerstoft, Jan ; Cairns, Gus. / Earlier testing for HIV--how do we prevent late presentation?. In: Antiviral Therapy. 2010 ; Vol. 15 Suppl 1. pp. 17-24.

Bibtex

@article{26ee9a1babb44704833252cefaab0c61,
title = "Earlier testing for HIV--how do we prevent late presentation?",
abstract = "HIV testing policies and practices vary widely across Europe. It is clear that there are individuals who might present late for HIV diagnosis and care within all risk groups, and potentially in any healthcare setting. This article explores the need to ensure earlier identification and treatment of late-presenting patients by reviewing strategies that might be considered. Such strategies could include routine provider-initiated HIV testing of at-risk groups in settings such as sexually transmitted infection clinics, drug dependency programmes or antenatal care. Healthcare providers might also consider routine HIV testing in all healthcare facilities, in settings including emergency and primary care, where local HIV prevalence is above a threshold that should be further evaluated. They should also take advantage of rapid testing technologies and be aware of barriers to HIV testing among specific groups to provide opportunities for testing that are relevant to local communities.",
author = "Yazdan Yazdanpanah and Joep Lange and Jan Gerstoft and Gus Cairns",
year = "2010",
month = jan,
day = "1",
doi = "http://dx.doi.org/10.3851/IMP1526",
language = "English",
volume = "15 Suppl 1",
pages = "17--24",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press",

}

RIS

TY - JOUR

T1 - Earlier testing for HIV--how do we prevent late presentation?

AU - Yazdanpanah, Yazdan

AU - Lange, Joep

AU - Gerstoft, Jan

AU - Cairns, Gus

PY - 2010/1/1

Y1 - 2010/1/1

N2 - HIV testing policies and practices vary widely across Europe. It is clear that there are individuals who might present late for HIV diagnosis and care within all risk groups, and potentially in any healthcare setting. This article explores the need to ensure earlier identification and treatment of late-presenting patients by reviewing strategies that might be considered. Such strategies could include routine provider-initiated HIV testing of at-risk groups in settings such as sexually transmitted infection clinics, drug dependency programmes or antenatal care. Healthcare providers might also consider routine HIV testing in all healthcare facilities, in settings including emergency and primary care, where local HIV prevalence is above a threshold that should be further evaluated. They should also take advantage of rapid testing technologies and be aware of barriers to HIV testing among specific groups to provide opportunities for testing that are relevant to local communities.

AB - HIV testing policies and practices vary widely across Europe. It is clear that there are individuals who might present late for HIV diagnosis and care within all risk groups, and potentially in any healthcare setting. This article explores the need to ensure earlier identification and treatment of late-presenting patients by reviewing strategies that might be considered. Such strategies could include routine provider-initiated HIV testing of at-risk groups in settings such as sexually transmitted infection clinics, drug dependency programmes or antenatal care. Healthcare providers might also consider routine HIV testing in all healthcare facilities, in settings including emergency and primary care, where local HIV prevalence is above a threshold that should be further evaluated. They should also take advantage of rapid testing technologies and be aware of barriers to HIV testing among specific groups to provide opportunities for testing that are relevant to local communities.

U2 - http://dx.doi.org/10.3851/IMP1526

DO - http://dx.doi.org/10.3851/IMP1526

M3 - Journal article

VL - 15 Suppl 1

SP - 17

EP - 24

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

ER -

ID: 34052019